2024

• Januszewski, A., Grzelka-Wozniak, A., Flotynska, J., Jenkins, A., Zozulinska-Ziolkiewicz, D., Uruska, A. (2024). An online tool using clinical factors to estimate the probability of partial clinical remission of adult-onset Type 1 diabetes. Journal of Diabetes and Its Complications, 38(9), 108828. [More Information]
• O'Hara, D., Lam, C., McMurray, J., Yi, T., Hocking, S., Dawson, J., Raichand, S., Januszewski, A., Jardine, M. (2024). Applications of SGLT2 inhibitors beyond glycaemic control. Nature Reviews Nephrology, 20(8), 513-529. [More Information]
• Tucker, W., Tucker, B., Januszewski, A., Jenkins, A., Keech, A., Kestenbaum, B., Allison, M., Rye, K., Ong, K. (2024). Association of circulating fibroblast growth factor 21 levels with all-cause and cardiovascular mortality: The multi-ethnic study of atherosclerosis. Clinica Chimica Acta, 555, 117799. [More Information]
• Januszewski, A., Young, H., Ong, K., Li, L., O'Connell, R., Lyons, T., Kelly, C., Zaharieva, D., Sullivan, D., Scott, R., Keech, A., Jenkins, A. (2024). Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate. Journal of Diabetes Investigation, 15(11), 1663-1668. [More Information]
• Januszewski, A., Blake, R., Zhang, M., Ma, B., Anand, S., Pinkert, C., Kelly, D., Jenkins, A., Trounce, I. (2024). Increased Diabetes Complications in a Mouse Model of Oxidative Stress Due to ‘Mismatched’ Mitochondrial DNA. Antioxidants, 13(2). [More Information]
• Mutter, S., Parente, E., Januszewski, A., Simonsen, J., Harjutsalo, V., Groop, P., Jenkins, A., Thorn, L. (2024). Insulin sensitivity estimates and their longitudinal association with coronary artery disease in type 1 diabetes. Does it matter? Cardiovascular Diabetology, 23(1). [More Information]
• Januszewski, A., Niedzwiecki, P., Sachithanandan, N., Ward, G., O’Neal, D., Zozulinska-Ziolkiewicz, D., Uruska, A., Jenkins, A. (2024). Interactive calculator to estimate insulin sensitivity in type 1 diabetes. Journal of Diabetes Investigation. [More Information]
• Jenkins, A., O'Connell, R., Januszewski, A., Webster, A., Davis, T., Jardine, M., Scott, R., Taskinen, M., Keech, A. (2024). Not enough known about fenofibrate’s kidney effects in people with Type 2 diabetes. Diabetes Research and Clinical Practice, 210, 111612-111612. [More Information]

2023

• Chen, D., Petrie, J., Jenkins, A., Greenlaw, N., Dudman, K., Fernandes, T., Carty, D., Hughes, A., Januszewski, A., Stehouwer, C. (2023). Cardiometabolic risk factors, peripheral arterial tonometry and metformin in adults with type 1 diabetes participating in the REducing with MetfOrmin Vascular Adverse Lesions trial. Diabetes and Vascular Disease Research, 20(3). [More Information]
• Huang, L., Januszewski, A., Takahashi, Y., O'Neal, D., Ma, J., Jenkins, A. (2023). Increased intracellular miR-142 in adults with Type 1 diabetes. Journal of Diabetes and Its Complications, 37(10). [More Information]
• Januszewski, A., Niedzwiecki, P., Sachithanandan, N., Ward, G., Karschimkus, C., O'Neal, D., Zozulinska-Ziolkiewicz, D., Uruska, A., Jenkins, A. (2023). Independent euglycaemic hyperinsulinaemic clamp studies validate clinically applicable formulae to estimate insulin sensitivity in people with type 1 diabetes. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 17(1). [More Information]
• O'Rourke, M., Januszewski, A., Sullivan, D., Lengyel, I., Stewart, A., Arya, S., Ma, R., Galande, S., Hardikar, A., Joglekar, M., Keech, A., Jenkins, A., Molloy, M. (2023). Optimised plasma sample preparation and LC-MS analysis to support large-scale proteomic analysis of clinical trial specimens: Application to the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial. Proteomics - Clinical Applications. [More Information]
• Brazionis, L., Quinn, N., Dabbah, S., Ryan, C., Møller, D., Richardson, H., Keech, A., Januszewski, A., Grauslund, J., Rasmussen, M., Jenkins, A., et al (2023). Review and comparison of retinal vessel calibre and geometry software and their application to diabetes, cardiovascular disease, and dementia. Graefe's Archive for Clinical and Experimental Ophthalmology. [More Information]

2022

• Quinn, N., Januszewski, A., Brazionis, L., O'Connell, R., Aryal, N., O'Day, J., Scott, R., Mitchell, P., Jenkins, A., Keech, A. (2022). Fenofibrate, which reduces risk of sight-threatening diabetic retinopathy in type 2 diabetes, is associated with early narrowing of retinal venules: a FIELD trial substudy. Internal Medicine Journal, 52(4), 676-679. [More Information]
• Hensman, C., Gooley, J., Januszewski, A., Lee, M., MacIsaac, R., Boston, R. (2022). Insulin antibodies are prevalent in adults with type 1 diabetes referred for islet cell transplantation and are modified by islet transplantation and immunosuppression: an Australian experience. Internal Medicine Journal, 52(8), 1434-1436. [More Information]
• Januszewski, A., Velayutham, V., Benitez-Aguirre, P., Craig, M., Cusumano, J., Pryke, A., Hing, S., Liew, G., Cho, Y., Chew, E., Jenkins, A., Donaghue, K. (2022). Optimal Frequency of Retinopathy Screening in Adolescents With Type 1 Diabetes: Markov Modeling Approach Based on 30 Years of Data. Diabetes Care, 45(10), 2383-2390. [More Information]
• Rao, B., Quinn, N., Januszewski, A., Peto, T., Brazionis, L., Aryal, N., O'Connell, R., Li, L., Summanen, P., Scott, R., Keech, A., Jenkins, A., et al (2022). Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy. Diabetes Research and Clinical Practice, 186, 109835-1-109835-6. [More Information]
• Syreeni, A., Carroll, L., Mutter, S., Januszewski, A., Forsblom, C., Lehto, M., Groop, P., Jenkins, A. (2022). Telomeres do not always shorten over time in individuals with type 1 diabetes. Diabetes Research and Clinical Practice, 188. [More Information]
• Jenkins, A., Syreeni, A., Mutter, S., Januszewski, A., Groop, P. (2022). Telomeres in clinical diabetes research - Moving towards precision medicine in diabetes care? Diabetes Research and Clinical Practice, 194, 110178. [More Information]

2021

• Scott, E., Januszewski, A., Carroll, L., Fulcher, G., Joglekar, M., Hardikar, A., Jones, T., Davis, E., Jenkins, A. (2021). Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes. Scientific Reports, 11(1), 16656. [More Information]
• Cheng, F., Carroll, L., Joglekar, M., Januszewski, A., Wong, K., Hardikar, A., Jenkins, A., Ma, R. (2021). Diabetes, metabolic disease, and telomere length. The Lancet Diabetes and Endocrinology, 9(2), 117-126. [More Information]
• Quinn, N., Jenkins, A., Ryan, C., Januszewski, A., Peto, T., Brazionis, L. (2021). Imaging the eye and its relevance to diabetes care. Journal of Diabetes Investigation, 12(6), 897-908. [More Information]
• Januszewski, A., Cho, Y., Joglekar, M., Farr, R., Scott, E., Wong, W., Carroll, L., Loh, Y., Benitez-Aguirre, P., Keech, A., Craig, M., Hardikar, A., Donaghue, K., Jenkins, A., et al (2021). Insulin micro-secretion in Type 1 diabetes and related microRNA profiles. Scientific Reports, 11(1), 11727. [More Information]
• Wong, W., Joglekar, M., Saini, V., Jiang, G., Dong, C., Chaitarvornkit, A., Maciag, G., Gerace, D., Farr, R., Satoor, S., Sahu, S., Sharangdhar, T., Ahmed, A., Chew, Y., Liuwantara, D., Hunter, J., Januszewski, A., Gamble, J., O'Connell, P., Hawthorne, W., et al (2021). Machine learning workflows identify a microRNA signature of insulin transcription in human tissues. iScience, 24(4), 102379. [More Information]
• Januszewski, A., Chen, D., Scott, R., O'Connell, R., Aryal, N., Sullivan, D., Watts, G., Taskinen, M., Barter, P., Best, J., Simes, R., Keech, A., Jenkins, A. (2021). Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes. Scientific Reports, 11(1), 18708. [More Information]
• Januszewski, A., Xu, D., Cho, Y., Benitez-Aguirre, P., O'Neal, D., Craig, M., Donaghue, K., Jenkins, A. (2021). Skin autofluorescence in people with type 1 diabetes and people without diabetes: An eight-decade cross-sectional study with evidence of accelerated aging and associations with complications. Diabetic Medicine, 38(7), e14432. [More Information]
• Ong, K., Wu, L., Januszewski, A., O'Connell, R., Xu, A., Scott, R., Sullivan, D., Rye, K., Li, H., Ma, R., Li, L., Gebski, V., Jenkins, A., Keech, A., et al (2021). The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-study. Diabetes and Vascular Disease Research, 18(4). [More Information]

2020

• Barraclough, J., Joglekar, M., Januszewski, A., Martínez, G., Celermajer, D., Keech, A., Hardikar, A., Patel, S. (2020). A MicroRNA Signature in Acute Coronary Syndrome Patients and Modulation by Colchicine. Journal of Cardiovascular Pharmacology and Therapeutics, 25(5), 444-455. [More Information]
• Januszewski, A., Sachithanandan, N., Ward, G., Karschimkus, C., O'Neal, D., Jenkins, A. (2020). Estimated insulin sensitivity in Type 1 diabetes adults using clinical and research biomarkers. Diabetes Research and Clinical Practice, 167, 108359. [More Information]
• Januszewski, A., Watson, C., O’Neill, V., McDonald, K., Ledwidge, M., Robson, T., Jenkins, A., Keech, A., McClements, L. (2020). FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease. Scientific Reports, 10(1), 1-8. [More Information]
• Scott, E., Januszewski, A., O'Connell, R., Fulcher, G., Scott, R., Kesaniemi, A., Wu, L., Colagiuri, S., Keech, A., Jenkins, A. (2020). Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study. Journal of Clinical Endocrinology and Metabolism, 105(10), 1-12. [More Information]
• Handrinos, L., Januszewski, A., Trimble, E., Donelan, N., Williams, P., Jenkins, A. (2020). Point-of-care testing of HbA1c, renal function and lipids in remote or disadvantaged regions. Internal Medicine Journal, 50(12), 1567-1571. [More Information]
• Ong, K., Wu, L., Januszewski, A., O'Connell, R., Xu, A., Rye, K., Ma, R., Li, H., Jenkins, A., Jia, W., Keech, A. (2020). Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study. Diabetes Research and Clinical Practice, 169, 108450. [More Information]
• Scott, E., McGrath, R., Januszewski, A., Fulcher, G., Jenkins, A. (2020). Short-term glucose variability in adults with Type 1 diabetes does not differ between insulin pump and multiple daily injection users - a masked continuous glucose monitoring study in clinical practice. Diabetes and Metabolism, 46(2), 172-174. [More Information]
• Furler, J., O'Neal, D., Speight, J., Blackberry, I., Manski-Nankervis, J., Thuraisingam, S., de La Rue, K., Ginnivan, L., Doyle, R., Holmes-Truscott, E., Jenkins, A., Januszewski, A., et al (2020). Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial. The Lancet Diabetes & Endocrinology, 8(1), 17-26. [More Information]

2019

• Aulich, J., Cho, Y., Januszewski, A., Craig, M., Selvadurai, H., Wiegand, S., Jenkins, A., Donaghue, K. (2019). Associations between circulating inflammatory markers, diabetes type and complications in youth. Pediatric Diabetes, 20(8), 1118-1127. [More Information]
• Mann Zhuang Mills, J., Januszewski, A., Robinson, B., Traill, C., Jenkins, A., Keech, A. (2019). Attractions and barriers to Australian physician-researcher careers. Internal Medicine Journal, 49(2), 171-181. [More Information]
• Scott, E., McGrath, R., Januszewski, A., Calandro, D., Hardikar, A., O'Neal, D., Fulcher, G., Jenkins, A. (2019). HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment. BMJ Open, 9(12), 1-8. [More Information]
• Ong, K., Hui, N., Januszewski, A., Kaakoush, N., Xu, A., Fayyad, R., DeMicco, D., Jenkins, A., Keech, A., Waters, D., et al (2019). High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the treating to new targets [TNT] study). Metabolism: Clinical and Experimental, 93, 93-99. [More Information]
• Gyawali, P., Martin, S., Heilbronn, L., Vincent, A., Jenkins, A., Januszewski, A., Adams, R., O'Loughlin, P., Wittert, G. (2019). Higher Serum Sex Hormone-Binding Globulin Levels Are Associated With Incident Cardiovascular Disease in Men. Journal of Clinical Endocrinology and Metabolism, 104(12), 6301-6315. [More Information]
• Sørensen, A., Udesen, P., Maciag, G., Geiger, J., Saliani, N., Januszewski, A., Hardikar, A., Jiang, G., Ma, R., Wissing, M., et al (2019). Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome. Frontiers in Medicine, 6, 1-13. [More Information]
• Jenkins, A., Januszewski, A., O'Neal, D. (2019). The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it. Cardiovascular Endocrinology & Metabolism, 8(1), 14-27. [More Information]

2018

• Gyawali, P., Martin, S., Heilbronn, L., Vincent, A., Jenkins, A., Januszewski, A., Taylor, A., Adams, R., O'Loughlin, P., Wittert, G. (2018). Cross-sectional and longitudinal determinants of serum sex hormone binding globulin (SHBG) in a cohort of community-dwelling men. PloS One, 13(7), 1-15. [More Information]
• Fuller, N., Salis (nee Sainsbury), A., Caterson, I., Denyer, G., Fong, M., Gerofi, J., Leung, H., Lau, N., Williams, K., Januszewski, A., Jenkins, A., Markovic, T. (2018). Effect of a high-egg diet on cardiometabolic risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) Study-randomized weight-loss and follow-up phase. American Journal of Clinical Nutrition, 107(6), 921-931. [More Information]
• Larsson, C., Januszewski, A., McGrath, R., Ludvigsson, J., Keech, A., MacIsaac, R., Ward, G., O'Neal, D., Fulcher, G., Jenkins, A. (2018). Suboptimal behaviour and knowledge regarding overnight glycaemia in adults with Type 1 diabetes is common. Internal Medicine Journal, 48(9), 1080-1086. [More Information]
• Jenkins, A., Kilov, G., Scott, E., Fulcher, G., O'Neal, D., Januszewski, A. (2018). Type 1 Diabetes Glucose Control Related Home-based Testing: A Mini-Review of Tools and Patient Knowledge and Implementation. Madridge Journal of Diabetes, 2(2), 55-62. [More Information]

2017

• Ong, K., O'Connell, R., Januszewski, A., Jenkins, A., Xu, A., Sullivan, D., Barter, P., Scott, R., Taskinen, M., Waldman, B., Simes, R., Rye, K., Keech, A., et al (2017). Baseline circulating FGF21 concentrations and increase after fenofibrate treatment predict more rapid glycemic progression in type 2 diabetes: Results from the FIELD study. Clinical Chemistry, 63(7), 1261-1270. [More Information]
• Benitez-Aguirre, P., Januszewski, A., Cho, Y., Craig, M., Jenkins, A., Donaghue, K. (2017). Early changes of arterial elasticity in Type 1 diabetes with microvascular complications - A cross-sectional study from childhood to adulthood. Journal of Diabetes and Its Complications, 31(12), 1674-1680. [More Information]
• Cho, Y., Craig, M., Januszewski, A., Benitez-Aguirre, P., Hing, S., Jenkins, A., Donaghue, K. (2017). Higher skin autofluorescence in young people with Type 1 diabetes and microvascular complications. Diabetic Medicine, 34(4), 543-550. [More Information]
• Bai, P., Wittert, G., Taylor, A., Martin, S., Milne, R., Jenkins, A., Januszewski, A., Shi, Z. (2017). The association between total phthalate concentration and non-communicable diseases and chronic inflammation in South Australian urban dwelling men. Environmental Research, 158, 366-372. [More Information]
• Sabanayagam, C., Lye, W., Januszewski, A., Banu Binte Mohammed Abdul, R., Cheung, G., Kumari, N., Wong, T., Cheng, C., Lamoureux, E. (2017). Urinary Isoprostane Levels and Age-Related Macular Degeneration. Investigative Ophthalmology and Visual Science, 58(5), 2538-2543. [More Information]

2016

• Joglekar, M., Januszewski, A., Jenkins, A., Hardikar, A. (2016). Circulating microRNA Biomarkers of Diabetic Retinopathy. Diabetes, 65(1), 22-24. [More Information]
• Tully, P., Baumeister, H., Martin, S., Atlantis, E., Jenkins, A., Januszewski, A., O'Loughlin, P., Taylor, A., Wittert, G. (2016). Elucidating the Biological Mechanisms Linking Depressive Symptoms With Type 2 Diabetes in Men: The Longitudinal Effects of Inflammation, Microvascular Dysfunction, and Testosterone. Psychosomatic Medicine, 78(2), 221-232. [More Information]
• Ogle, G., Abdullah, M., Mason, D., Januszewski, A., Besancon, S. (2016). Insulin storage in hot climates without refrigeration: temperature reduction efficacy of clay pots and other techniques. Diabetic Medicine, 33(11), 1544-1553. [More Information]
• Kar, P., Plummer, M., Bellomo, R., Jenkins, A., Januszewski, A., Chapman, M., Jones, K., Horowitz, M., Deane, A. (2016). Liberal Glycemic Control in Critically Ill Patients with Type 2 Diabetes: An Exploratory Study. Critical Care Medicine, 44(9), 1695-1703. [More Information]
• Li, J., Wittert, G., Vincent, A., Atlantis, E., Shi, Z., Appleton, S., Hill, C., Jenkins, A., Januszewski, A., Adams, R. (2016). Muscle grip strength predicts incident type 2 diabetes: Population-based cohort study. Metabolism: Clinical and Experimental, 65(6), 883-892. [More Information]
• Williams, K., Sullivan, D., Nicholson, G., George, J., Jenkins, A., Januszewski, A., Gebski, V., Manning, P., Tan, Y., Donoghoe, M., Buizen, L., Twigg, S., Keech, A., et al (2016). Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Metabolism: Clinical and Experimental, 65(5), 783-793. [More Information]
• Januszewski, A., Sutanto, S., McLennan, S., O'Neal, D., Keech, A., Twigg, S., Jenkins, A. (2016). Shorter telomeres in adults with Type 1 diabetes correlate with diabetes duration, but only weakly with vascular function and risk factors. Diabetes Research and Clinical Practice, 117, 4-11. [More Information]
• Traill, C., Januszewski, A., Larkins, R., Keech, A., Jenkins, A. (2016). Time to research Australian female physician-researchers. Internal Medicine Journal, 46(4), 412-419. [More Information]
• Traill, C., Januszewski, A., Larkins, R., Keech, A., Jenkins, A. (2016). Time to research Australian physician-researchers. Internal Medicine Journal, 46(5), 550-558. [More Information]

2015

• Farr, R., Januszewski, A., Joglekar, M., Liang, H., McAulley, A., Hewitt, A., Thomas, H., Loudovaris, T., Kay, T., Jenkins, A., Hardikar, A. (2015). A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy. Scientific Reports, 5, 1-13. [More Information]
• Jenkins, A., Joglekar, M., Hardikar, A., Keech, A., O'Neal, D., Januszewski, A. (2015). Biomarkers in Diabetic Retinopathy. The Review of Diabetic Studies, 12(1-2), 159-195. [More Information]
• Pipingas, A., Sinclair, A., Croft, K., Januszewski, A., Jenkins, A., Mori, T., Cockerell, R., Grima, N., Stough, C., Scholey, A., et al (2015). Fish oil and multivitamin supplementation reduces oxidative stress but not inflammation in healthy older adults: A randomised controlled trial. Journal of Functional Foods, 19, 949-957. [More Information]
• Martin, S., Vincent, A., Taylor, A., Atlantis, E., Jenkins, A., Januszewski, A., O'Loughlin, P., Wittert, G. (2015). Lower Urinary Tract Symptoms, Depression, Anxiety and Systemic Inflammatory Factors in Men: A Population-Based Cohort Study. PloS One, 10(10), 1-18. [More Information]
• Hardikar, A., Satoor, S., Karandikar, M., Joglekar, M., Puranik, A., Wong, W., Kumar, S., Limaye, A., Bhat, D., Januszewski, A., Keech, A., Jenkins, A., et al (2015). Multigenerational Undernutrition Increases Susceptibility to Obesity and Diabetes that Is Not Reversed after Dietary Recuperation. Cell Metabolism, 22(2), 312-319. [More Information]
• Wong, W., Farr, R., Joglekar, M., Januszewski, A., Hardikar, A. (2015). Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs. Journal of Visualized Experiments, 98, 1-12. [More Information]
• Ong, K., Januszewski, A., O'Connell, R., Buizen, L., Jenkins, A., Xu, A., Sullivan, D., Barter, P., Scott, R., Taskinen, M., Rye, K., Keech, A. (2015). Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia, 59(8), 2035-2044. [More Information]
• Tully, P., Baumeister, H., Bengel, J., Jenkins, A., Januszewski, A., Martin, S., Wittert, G. (2015). The longitudinal association between inflammation and incident depressive symptoms in men: The effects of hs-CRP are independent of abdominal obesity and metabolic disturbances. Physiology and Behavior, 139, 328-335. [More Information]
• Ong, K., Januszewski, A., O'Connell, R., Jenkins, A., Xu, A., Sullivan, D., Barter, P., Hung, W., Scott, R., Taskinen, M., Keech, A., Rye, K. (2015). The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia, 58(3), 464-473. [More Information]

2014

• Januszewski, A., Mason, N., Karschimkus, C., Rowley, K., Best, J., O'Neal, D., Jenkins, A. (2014). Plasma semicarbazide-sensitive amine oxidase activity in type 1 diabetes is related to vascular and renal function but not to glycaemia. Diabetes and Vascular Disease Research, 11(4), 262-269. [More Information]

2013

• Naser, N., Januszewski, A., Brown, B., Jenkins, A., Hill, M., Murphy, T. (2013). Advanced glycation end products acutely impair ca(2+) signaling in bovine aortic endothelial cells. Frontiers in Physiology, 4, 1-14. [More Information]

2012

• Januszewski, A., Sachithanandan, N., Karschimkus, C., o'neal, D., Yeung, C., Alkatib, N., Jenkins, A. (2012). Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Diabetic Medicine, 29(6), 726-733. [More Information]
• Januszewski, A., Karschimkus, C., Davis, K., O'Neal, D., Ward, G., Jenkins, A. (2012). Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: Assay assessment and lower levels in diabetic vs. non-diabetic subjects. Diabetes Research and Clinical Practice, 95(1), e17-e19. [More Information]

2010

• Januszewski, A., Harper, C., Jenkins, A., McBride, J., Karschimkus, C., Zhang, B., O'Neal, D., Nelson, C., Chung, J., Lyons, T., et al (2010). Increased serum kallistatin levels in type 1 diabetes patients with vascular complications. Journal of Angiogenesis Research, 2(1), 19-19. [More Information]
• Griffin, M., Wilson, L., Mok, Y., Januszewski, A., Wilson, A., Karschimkus, C., Romas, E., Lee, A., Godfrey, T., Wong, M., et al (2010). Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factors. Clinical Biochemistry, 43(3), 278-286. [More Information]

2009

• Valaydon, Z., Lee, P., Dale, G., Januszewski, A., Rowley, K., Nandurkar, H., Karschimkus, C., Best, J., Lyons, T., Jenkins, A. (2009). Increased coated-platelet levels in chronic haemodialysis patients. Nephrology, 14(2), 148-154. [More Information]

2008

• Januszewski, A., Thomas, M., Karschimkus, C., Chung, J., Rowley, K., Nelson, C., O'Neal, D., Dragicevic, G., Harper, C., Best, J., et al (2008). Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus. Journal of Medical Investigation, 55(1/2), 29-36. [More Information]

2007

• Jenkins, A., Zhang, S., Rowley, K., Karschimkus, C., Nelson, C., Chung, J., Januszewski, A., O'Neal, D., Croft, K., Mori, T., Harper, C., et al (2007). Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes. Diabetic Medicine, 24(12), 1345-1351. [More Information]
• Nobecourt, E., Davies, M., Brown, B., Curtiss, L., Bonnet, D., Charlton, F., Januszewski, A., Jenkins, A., Barter, P., Rye, K. (2007). The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. Diabetologia, 50(3), 643-653. [More Information]